Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin
David A
DA
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. david.fiellin@yale.edu
Kleber
Herbert
H
Trumble-Hejduk
Jeanne G
JG
McLellan
A Thomas
AT
Kosten
Thomas R
TR
D000553:Ambulatory Care; D002047:Buprenorphine / Q000627:therapeutic use*; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D017410:Practice Guidelines as Topic; D014481:United States
D009292:Narcotic Antagonists; D002047:Buprenorphine